LUZP4 and paraneoplastic neurologic syndrome: More recently, leucine zipper protein 4 (LUZP4) antibodies have been described in patients with neurological paraneoplastic syndromes, presenting as rhombencephalitis, limbic encephalitis, seizures and/or motor neuronopathy (163).